Skip to main content

NIAID to Fund Consortium for Rapid HIV MDx Test

NEW YORK (GenomeWeb News) — The National Institute of Allergy and Infectious Diseases expects to fund two reimbursement contracts for a period of five years, beginning next August, to support a consortium of scientists in developing a molecular diagnostic test for HIV.
 
The test will be a simple and rapid point-of-care diagnostic device that could be used in clinics that do not have lab equipment, such as pipettes and centrifuges, and which would require limited sample manipulation. NIAID said the test should generate results in a visual format with no ambiguity in the results.
 
Responses to the request for proposals are due by Dec. 2.
 
More information about the request may be found here.
 
 
 

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.